Effectiveness and Safety of the Colonoscopy With "Visualization" Balloon
A Randomized Controlled Trial to Evaluate Effectiveness and Safety of the Colonoscopy With the "Visualization" Balloon
Colonoscopy has become the "gold standard" in detection of colonic polyps and colon cancer. However, colonoscopy causes significant abdominal discomfort and abdominal pain during and after the procedure, requiring intravenous sedation and use of analgesics. The discomfort and pain are mostly caused by air insufflation and intubation difficulties during advancement of the colonoscope in order the reach the cecum.
Study Hypothesis: Use of the "Visualization" Balloon will facilitate advancement of the colonoscope and will eliminate the need for colonic distention with the air or CO2, which can shortened the length of the procedure, reduce patient's discomfort and can decrease amount of sedatives and analgesics used during colonoscopy.
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Yksityiskohtainen kuvaus
The goal of this study is to evaluate effectiveness and safety of a "Visualization" Balloon for performance of colonoscopy.
Our hypothesis is that, use of "Visualization" Balloon will decrease colonic distention, patient's discomfort, use of sedatives and analgetics during procedure and will simplify the performance of colonoscopy resulting in shortening of procedure time and increasing the rate of cecal intubation.
Specific aims of the study:
- To compare procedure time and effectiveness of the "Visualization" Balloon colonoscopy with traditional CO2-insufflation colonoscopy.
- To compare safety profiles between traditional CO2-insufflation colonoscopy and colonoscopy using the "Visualization" Balloon.
4 STUDY ENDPOINTS 4.1 Primary Outcome To compare the mean cecal intubation time achieved with "Visualization" Balloon colonoscopy, with the mean cecal intubation time achieved with standard colonoscopy using CO2 insufflation.
4.2 Secondary Outcomes
To compare "Visualization" Balloon colonoscopy with standard CO2-insufflation colonoscopy in regards of:
- Total amount of carbon dioxide (CO2) gas for colonic insufflation used during the procedure.
- Ease of colonoscope insertion.
- The length of the colonoscope when it reaches the cecum. 4 Colonoscope withdrawal time and total procedure time.
5. Cecal intubation rate. 6. Total dosage of analgesics and sedative during procedure. 7. Patient satisfaction: perceived pain and discomfort immediately after the procedure and in 24 hours post procedure.
8. Complications during and after colonoscopy. 9. Polyp detection rate.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Maryland
-
Baltimore, Maryland, Yhdysvallat, 21202
- Mercy Medical Center
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- The patient is undergoing colonoscopy for colo-rectal cancer screening, polypectomy or for diagnostic workup.
- Subject is able to understand the risks and benefits of participating in the study and must be willing to sign and date the Informed Consent Form for this study approved by the Institutional Review Board (IRB.)
- Age from 17 to 90 years.
- Be willing and able to comply with the requirements of the protocol.
- Be willing to refrain from participating in any other investigational interventional study while enrolled in this study.
- Female subjects must have a negative pregnancy test within the last 24 hours timeline and have no intentions of becoming pregnant during participation in the study, or be sterilized.
Exclusion Criteria:
- Subjects with a history of previous colonic resection.
- Subjects with uncorrectable bleeding disorders (INR more than 1.5, platelet count less than 50,000).
- Subjects unwilling or unable to give written consent to participate in the investigation or unable to comply with the requirements of the protocol.
- Subjects with suspected colonic strictures potentially precluding complete colonoscopy.
- Subjects who received any experimental drug or device within the previous three months.
- Female subjects who were pregnant or lactating or were intending to become pregnant during the period of the study, or who would not use an adequate method of contraception (contraceptive pill, intra-uterine device) for the duration of the study.
- Subjects who possessed any psychological condition, or were under treatment for any condition which, in the opinion of the Investigator and/or consulting physicians(s), would constitute an unwarranted risk.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Diagnostiikka
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Visualization balloon
Colonoscopy performed with the use of "Visualization" balloon
|
The "Visualization" Balloon is a disposable medical device that is used during the advancement of the colonoscope inside the colon.
The intended use of the "Visualization" Balloon is to help insertion of the colonoscope into the colon without the aid of gas (air or CO2) insufflation as with standard colonoscopy.
The "Visualization" Balloon is inserted through the biopsy channel of the colonoscope prior to the colonoscope introduction into the rectum.
The "Visualization" Balloon is an inflatable balloon that opens up the lumen of the gastrointestinal tract, thereby allowing the endoscopist to advance the endoscope inside and to view the gastrointestinal tract through the clear balloon.
|
|
Active Comparator: Traditional CO2-insufflation colonoscopy
Traditional colonoscopy performed with CO2 insufflation without "Visualization" balloon
|
Traditional colonoscopy performed with CO2 insufflation without "Visualization" balloon
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Cecal intubation time
Aikaikkuna: Immediately
|
Time required to reach cecum
|
Immediately
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Length of colonoscope when it reaches cecum
Aikaikkuna: Immediately
|
Total length of colonoscope when it reaches cecum
|
Immediately
|
|
Ease of colonoscope insertion
Aikaikkuna: Immediate
|
Easy of colonoscope insertion to cecum
|
Immediate
|
|
Dose of analgesics and sedatives used
Aikaikkuna: Immediately
|
Dose of analgesics and sedatives used during insertion and total dose for the entire procedure
|
Immediately
|
|
Patient satisfaction
Aikaikkuna: Immediately and in 24 hours
|
Patient satisfaction: perceived pain and discomfort immediately after the procedure and in 24 hours post procedure.
|
Immediately and in 24 hours
|
|
Total procedure time
Aikaikkuna: Immediately
|
Total time required to complete colonoscopy
|
Immediately
|
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Amount of carbon dioxide used
Aikaikkuna: Immediately
|
Total amount of carbon dioxide used during colonoscopy
|
Immediately
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Sergey V Kantsevoy, MD, PhD, Mercy Medical Center
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- VB-001
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Paksusuolen adenomatoottiset polyypit
-
Assistance Publique Hopitaux De MarseilleEi vielä rekrytointiaCrohnin tauti | Anastomoottinen vuoto peräsuolessa | Kolorektaalinen anastomoosi | Adenomatous Polyposis Coli, perhe | Endometrium | Haavainen paksusuolitulehdus (häiriö) | Ruoansulatuskanavan syövät | SuojaRanska
-
Assistance Publique - Hôpitaux de ParisAxcan PharmaTuntematonAdenomatous Polyposis Coli, perheRanska
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Valmis15-lipoksigenaasi-1:n (15-LOX-1) molekyylikohdistus ihmisen kolorektaalisyövän apoptoosin induktioonPerheellinen adenomatoottinen polypoosiYhdysvallat
-
National Cancer Institute (NCI)ValmisPerheellinen adenomatoottinen polypoosiYhdysvallat
-
Yonsei UniversityValmisPerheellinen adenomatoottinen polypoosiKorean tasavalta
-
London North West Healthcare NHS TrustTuntematonPerheellinen adenomatoottinen polypoosiYhdistynyt kuningaskunta
-
Sahlgrenska University HospitalValmisFamiliaalinen adenomatoottinen polypoosi (FAP) | Haavainen paksusuolitulehdus (häiriö)Ruotsi
-
Azienda USL Reggio Emilia - IRCCSValmisPerheellinen adenomatoottinen polypoosi | Ampullaarinen adenooma
-
Mansoura UniversityValmisHaavainen paksusuolitulehdus | Perheellinen adenomatoottinen polypoosi
-
Changhai HospitalEi vielä rekrytointia
Kliiniset tutkimukset Visualization balloon
-
Ankara Yildirim Beyazıt UniversityValmis
-
Ankara Yildirim Beyazıt UniversityValmis